Cargando…
Transient Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection in Proliferative Diabetic Retinopathy Patients: A Prospective Study
Introduction: The clinical use of intravitreal bevacizumab (IVB), a recombinant humanized monoclonal antibody that functions as an anti-vascular endothelial growth factor (anti-VEGF), has recently increased in patients with retinal ischemic diseases such as proliferative diabetic retinopathy (PDR)....
Autores principales: | Luqman, Faizan, Bibi, Hafsa, Mukhtar, Marwa, Zafar, Fahad, Ahmed, Hafsa, Khizer, Muhammad A, Gul, Nazli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578873/ https://www.ncbi.nlm.nih.gov/pubmed/37849604 http://dx.doi.org/10.7759/cureus.45371 |
Ejemplares similares
-
Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008) -
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020) -
A Rare Case of Post-Traumatic Posterior Chamber Intraocular Lens Extrusion Through the Scleral Tunnel of Manual Small Incision Cataract Surgery
por: Luqman, Faizan, et al.
Publicado: (2023) -
Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007) -
The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
por: Al-Kharashi, Abdullah, et al.
Publicado: (2016)